Tilray Brands reported a first-quarter revenue record, rising 23% year-over-year, driven by gains in its beer and distribution segments following the BrewDog acquisition. However, its core cannabis sales declined, falling to $56.1 million, causing investor concern and a 4% drop in its stock price. Despite higher revenue and gross profit, adjusted earnings before interest, taxes, depreciation, and amortization decreased due to factors like global fuel surcharges. The company remains optimistic with a net cash position and reduced debt, but the market will watch closely to see if cannabis sales stabilize and profitability improves in coming quarters. Canopy Growth and Aurora Cannabis, more focused on cannabis, showed smaller stock declines, indicating Tilray's mixed results are company-specific rather than sector-wide.
Tilray Brands' mixed earnings results are mirrored in its stock performance on Pluang, where TLRY is down 3.36% at USD 3.59 as of Oct 08, 2026 21:21 WIB. Canopy Growth and Aurora Cannabis, which focus more on cannabis, show smaller declines of 1.88% and 1.35% respectively, trading at USD 0.86 and USD 4.40. This suggests that Tilray's challenges are more company-specific rather than reflecting the broader cannabis sector.
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
Tilray Inc reported a record first-quarter revenue of $257.1 million, up 23% year-over-year, fueled by strong growth in its beverage segment and international markets. Beverage revenue surged 82% to $101.5 million, boosted by the BrewDog acquisition,...
Tilray Brands reported a record first-quarter fiscal 2027 revenue of $257 million, a 23% increase year-over-year, with gross profit rising 35% to $77.5 million and gross margin expanding to 30%. Growth was led by the beverage segment, which surged 82...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
